C-myc-driven polyamine metabolism in ovarian cancer: from pathogenesis to early detection and therapy

HIGHLIGHTS

  • who: Yihui Chen et al. from the Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA have published the paper: c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy, in the Journal: Cancers 2023, 15, 623. of /2023/
  • what: C-MYC and its paralogues are among the most frequently amplified and/or overexpressed oncoproteins in ovarian cancer.

SUMMARY

    The authors additionally highlight opportunities for exploiting c-MYC-driven polyamine metabolism for early detection and therapeutic applications in ovarian . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?